fda compounding restrictions bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank A step towards expanded patient
A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! BREAKING: U.S. Regulators to Review Controversial Peptides Backed by RFK Jr. U.S. health regulators are preparing to review whether several controversial peptide compounds should be allowed to be made by compounding The FDA cracked down on BPC 157 and now the biohackers are losing their minds The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14

